Ha habido 50 transacciones internas recientes registradas para InspireMD, Inc. (NSPR), incluyendo 32 compras y 14 ventas. El total de compras internas fue valorado en $2.3M y el total de ventas internas en $389.69K.
Internos destacados con actividad reciente incluyen Gleason Shane Thomas, Roubin Gary S, Ward Scott R.. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — NSPR
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2026-02-02 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
2,000 |
$1.60 |
$3.21K |
1,139,177 |
| 2026-01-30 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
2,900 |
$1.63 |
$4.73K |
1,141,177 |
| 2026-01-29 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
5,000 |
$1.65 |
$8.25K |
1,144,077 |
| 2026-01-28 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
12,395 |
$1.65 |
$20.46K |
1,149,077 |
| 2026-01-27 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
4,781 |
$1.66 |
$7.96K |
1,161,472 |
| 2026-01-22 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
8,411 |
$1.57 |
$13.24K |
1,166,253 |
| 2026-01-21 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
17,593 |
$1.62 |
$28.55K |
1,174,664 |
| 2026-01-20 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
2,955 |
$1.59 |
$4.71K |
1,192,257 |
| 2026-01-16 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
2,250 |
$1.61 |
$3.63K |
1,195,212 |
| 2026-01-15 |
Gleason Shane Thomas |
Chief Commercial Officer |
Venta Informativa |
2,909 |
$1.58 |
$4.59K |
1,197,462 |
| 2026-01-14 |
Roubin Gary S |
Director |
Concesión de RSU |
88,053 |
- |
- |
744,478 |
| 2026-01-14 |
Ward Scott R. |
Director |
Concesión de RSU |
88,053 |
- |
- |
147,846 |
| 2026-01-14 |
Berman Michael |
Director |
Concesión de RSU |
88,053 |
- |
- |
352,586 |
| 2026-01-14 |
Cohen Raymond W |
Director |
Concesión de RSU |
44,030 |
- |
- |
92,417 |
| 2026-01-14 |
Stuka Paul |
Director |
Concesión de RSU |
132,076 |
- |
- |
523,704 |
| 2026-01-14 |
Dearen Danny L. |
Director |
Concesión de RSU |
44,030 |
- |
- |
102,047 |
| 2026-01-14 |
Slosman Marvin |
CEO and President |
Concesión de RSU |
1,114,792 |
- |
- |
3,535,658 |
| 2026-01-14 |
Lawless Michael A |
Chief Financial Officer |
Concesión de RSU |
226,695 |
- |
- |
691,695 |
| 2026-01-14 |
Gleason Shane Thomas |
Chief Commercial Officer |
Concesión de RSU |
453,390 |
- |
- |
1,200,371 |
| 2026-01-14 |
Tommasoli Andrea |
Chief Operating Officer |
Concesión de RSU |
226,695 |
- |
- |
954,389 |
| 2025-12-30 |
Arnold Kathryn |
Director |
Concesión de RSU |
26,276 |
$1.89 |
$49.66K |
111,221 |
| 2025-12-09 |
Stuka Paul |
Director |
Compra Informativa |
5,073 |
$1.81 |
$9.18K |
391,628 |
| 2025-12-05 |
Stuka Paul |
Director |
Compra Informativa |
5,073 |
$1.86 |
$9.44K |
388,918 |
| 2025-12-04 |
Stuka Paul |
Director |
Compra Informativa |
10,130 |
$1.85 |
$18.74K |
383,845 |
| 2025-11-12 |
Stuka Paul |
Director |
Compra Informativa |
13,431 |
$1.62 |
$21.76K |
373,715 |
| 2025-10-07 |
Roubin Gary S |
Director |
Concesión de RSU |
48,000 |
- |
- |
656,425 |
| 2025-09-16 |
Dearen Danny L. |
Director |
Desconocido |
28,206 |
$2.41 |
$67.98K |
- |
| 2025-09-15 |
Kester Thomas J |
Director |
Concesión de RSU |
19,041 |
$2.38 |
$45.32K |
19,041 |
| 2025-07-31 |
Cohen Raymond W |
Director |
Desconocido |
23,330 |
$2.79 |
$65.09K |
- |
| 2025-07-30 |
Roubin Gary S |
Director |
Compra Informativa |
41,322 |
$2.42 |
$100K |
608,425 |
| 2025-07-30 |
Kester Thomas J |
Director |
Compra Informativa |
30,991 |
$2.42 |
$75K |
420,758 |
| 2025-07-30 |
Stuka Paul |
Director |
Compra Informativa |
20,661 |
$2.42 |
$50K |
444,195 |
| 2025-07-30 |
Slosman Marvin |
CEO and President |
Compra Informativa |
10,330 |
$2.42 |
$25K |
2,420,866 |
| 2025-07-11 |
Kester Thomas J |
Director |
Ejercicio de Opciones (ITM) |
30,624 |
$1.38 |
$42.34K |
- |
| 2025-07-01 |
Stuka Paul |
Director |
Ejercicio de Opciones (ITM) |
87,500 |
$1.38 |
$120.99K |
- |
| 2025-06-29 |
Berman Michael |
Director |
Ejercicio de Opciones (ITM) |
61,248 |
$1.38 |
$84.69K |
- |
| 2025-06-25 |
Lawless Michael A |
Chief Financial Officer |
Desconocido |
212,000 |
$2.24 |
$474.88K |
- |
| 2025-06-25 |
Roubin Gary S |
Director |
Ejercicio de Opciones (ITM) |
30,624 |
$1.38 |
$42.34K |
- |
| 2025-01-07 |
Roubin Gary S |
Director |
Concesión de RSU |
14,836 |
$2.71 |
$40.21K |
91,743 |
| 2025-01-07 |
Ward Scott R. |
Director |
Concesión de RSU |
7,418 |
$2.71 |
$20.1K |
24,065 |
| 2025-01-07 |
Berman Michael |
Director |
Concesión de RSU |
14,836 |
$2.71 |
$40.21K |
84,950 |
| 2025-01-07 |
Kester Thomas J |
Director |
Concesión de RSU |
14,836 |
$2.71 |
$40.21K |
84,947 |
| 2025-01-07 |
Shore Craig |
CFO and CAO |
Concesión de RSU |
106,218 |
$2.71 |
$287.85K |
417,706 |
| 2025-01-07 |
Stuka Paul |
Director |
Concesión de RSU |
22,254 |
$2.71 |
$60.31K |
128,129 |
| 2025-01-07 |
Verta Patrick |
EVP Clinical/medical Affairs |
Concesión de RSU |
37,933 |
$2.71 |
$102.8K |
117,281 |
| 2025-01-07 |
Slosman Marvin |
CEO and President |
Concesión de RSU |
254,985 |
$2.71 |
$691.01K |
937,796 |
| 2025-01-07 |
Arnold Kathryn |
Director |
Concesión de RSU |
14,836 |
$2.71 |
$40.21K |
84,945 |
| 2025-01-07 |
Gleason Shane Thomas |
Chief Commercial Officer |
Concesión de RSU |
106,218 |
$2.71 |
$287.85K |
289,346 |
| 2025-01-07 |
Tommasoli Andrea |
Chief Operating Officer |
Concesión de RSU |
106,218 |
$2.71 |
$287.85K |
282,917 |
| 2024-11-25 |
Ward Scott R. |
Director |
Desconocido |
16,647 |
$2.94 |
$48.94K |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
